Cancer Genetics
The Cancer Genetics (CG) Program is a basic science program centered on determining how mutations in—and altered expression of—specific genes contribute to cancer development, progression and treatment. Research in the CG Program aims to:
- Identify and characterize genes that promote or prevent cancer and can affect treatment by, for example, mediating drug resistance or immune evasion
- Determine the basis by which specific genes become aberrantly expressed or silenced during cancer development and how this dysregulation contributes to the neoplastic phenotype
- Develop and utilize novel animal model systems to study the impact of key genetic alterations found in human cancers
Leadership
Getting Results…
Members
Getting Results…
-
Victor Ambros, PhD
-
Neil Aronin, MD
-
Ingolf Bach, PhD
-
Sharon Cantor, PhD
-
Craig Ceol, PhD
-
Job Dekker, PhD
-
Thomas Fazzio, PhD
-
William A. Flavahan, PhD
-
Manuel Garber, PhD
-
Heather Gardner, DVM, PhD
-
In Memoriam: Michael R. Green, MD, PhD
-
Anne W. Higgins, PhD
-
Anthony N. Imbalzano, PhD
-
Joseph Jerry, PhD
-
Elinor Karlsson, PhD
-
Paul D. Kaufman, PhD
-
Jeanne B. Lawrence, PhD
-
Brian Lewis, PhD
-
Shaoguang Li, MD, PhD
-
Cheryl London, DVM, PhD
-
Sunil K. Malonia, PhD
-
Craig Mello, PhD
-
Patricia Minehart Miron, PhD
-
Athma Pai, PhD
-
Craig L. Peterson, PhD
-
Nick Rhind, PhD
-
Marcus Ruscetti, PhD
-
Karl Simin, PhD
-
Sakiko Suzuki, MD
-
Eduardo Torres, PhD
-
Emma Watson, PhD
-
Joae Wu, PhD
-
Phillip D. Zamore, PhD
-
Chan Zhou, PhD
-
Lihua Julie Zhu, PhD